Medicine Safety Declared an Australian National Health Priority Area
The Centre for Medicine Use and Safety (CMUS) at the Monash Institute of Pharmaceutical Sciences has welcomed Health Minister Greg Hunt’s declaration that Medicine Safety will become Australia’s tenth National Health Priority Area.
Minister Hunt made the declaration while speaking at the PSA19 Conference in Sydney.
A recent report published by the Pharmaceutical Society of Australia (PSA) suggested that medication-related problems are implicated in up to 250,000 hospital admissions each year in Australia, at a cost of $1.4 billion.
CMUS Director Professor Simon Bell said the Health Minister’s announcement provides clear recognition of the importance of safe and quality use of medicines.
“The need to develop and implement new evidence-based strategies to reduce the impact of medication-related harm has never been greater,” Professor Bell said.
“Our CMUS team is focused on working in partnership with clinicians, educators, researchers and policy makers in Australia and internationally to bring about improvements in medicine use and safety,” he said.
Medication Without Harm was announced as the Third World Health Organization Global Patient Safety Challenge in 2017.
Research about strategies to address medication-related harm will be showcased among other topics at the Australasian Pharmaceutical Science Association (APSA) Annual Conference to be hosted at Monash Parkville in December this year.